Pharmacological Evaluation of Humanized Anti-Epidermal Growth Factor Receptor, Monoclonal Antibody h-R3, in Patients With Advanced Epithelial-Derived Cancer

Article

Abstract: Epidermal growth factor receptor (EGFR) overexpression has been detected in many tumors of epithelia

Palabras claves:

Epidermal growth factor receptor, Monoclonal antibody, Phase I clinical trial

Autores:

Catala M., Iznaga N., Lage Davila A., Neninger Vinageras E., Perera A., Pérez R., Solano M., Tania Crombet, Torres F., Torres L., Torres O.

Fuentes:

scopus